A substance that diminishes the rate of a chemical reaction.
Member | Definition | Class |
2-furoic acid | A furoic acid having the carboxylic acid group located at position 2. | 2-furoic acid |
ARS-1620 | A qinazoline derivative carrying chloro and fluoro substituents at positions 6 and 8 respectively, a 2-fluoro-6-hydroxyphenyl group at position 7, and a 4-(prop-2-enoyl)piperazin-1-yl group at position 4. A potent, selective, and orally bioavailable covalent KRAS-G12C inhibitor, it inhibits the protein coding gene KRAS (Kirsten rat sarcoma virus) with high potency in cells and animals. | ARS-1620 |
beta-alanine | A naturally-occurring beta-amino acid comprising propionic acid with the amino group in the 3-position. | beta-alanine zwitterion; beta-alanine |
blister | A pyrroloquinoline that is 1,2,3,3a-tetrahydro-H-pyrrolo[2,3-b]quinolin-4-one substituted by a hydroxy group at position 3a, a methyl group at position 6 and a phenyl group at position 1. It acts as an inhibitor of ATPase activity of non-muscle myosin II. | blebbistatin |
glafenine | A carboxylic ester that is 2,3-dihydroxypropyl anthranilate in which the amino group is substituted by a 7-chloroquinolin-4-yl group. A non-steroidal anti-inflammatory drug, glafenine and its hydrochloride salt were used for the relief of all types of pain, but high incidence of anaphylactic reactions resulted in their withdrawal from the market. | glafenine |
limonin | | limonin |
medroxyprogesterone acetate | An acetate ester resulting from the formal condensation of the 17alpha-hydroxy group of medroxyprogesterone with the carboxy group of acetic acid. A widely used progestin in menopausal hormone therapy and in progestogen-only birth control. | medroxyprogesterone acetate |
parthenolide | A sesquiterpene lactone and active principle of Feverfew (Tanacetum parthenium). | parthenolide |
succinyl-coenzyme a | An omega-carboxyacyl-CoA having succinoyl as the S-acyl component. | succinyl-CoA |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 28.0076 | 1 | 3 |
Alpha-synuclein | Homo sapiens (human) | Potency | 5.6234 | 1 | 1 |
AR protein | Homo sapiens (human) | Potency | 2.7718 | 12 | 27 |
ATAD5 protein, partial | Homo sapiens (human) | Potency | 29.0810 | 1 | 1 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 36.1093 | 1 | 2 |
Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 26.6320 | 1 | 2 |
Chain A, Cruzipain | Trypanosoma cruzi | Potency | 35.7168 | 1 | 2 |
Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 25.1189 | 1 | 1 |
Chain A, HADH2 protein | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
Chain B, HADH2 protein | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
chromobox protein homolog 1 | Homo sapiens (human) | Potency | 79.4328 | 1 | 1 |
cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 3.0901 | 1 | 1 |
cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 11.8961 | 2 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 9.5953 | 1 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 1.7850 | 1 | 3 |
DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 7.0795 | 1 | 1 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 5.0456 | 7 | 11 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 20.8735 | 6 | 13 |
euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 6.8184 | 1 | 3 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 24.8464 | 4 | 5 |
G | Vesicular stomatitis virus | Potency | 3.0901 | 1 | 1 |
GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 11.8961 | 1 | 2 |
geminin | Homo sapiens (human) | Potency | 12.8597 | 2 | 5 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 19.2114 | 2 | 4 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 1.5197 | 5 | 12 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 0.0488 | 1 | 2 |
Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 19.7020 | 1 | 2 |
HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 3.0901 | 1 | 1 |
IDH1 | Homo sapiens (human) | Potency | 19.1465 | 1 | 2 |
Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 3.0901 | 1 | 2 |
Interferon beta | Homo sapiens (human) | Potency | 11.8278 | 2 | 4 |
interleukin 8 | Homo sapiens (human) | Potency | 74.9780 | 1 | 1 |
lamin isoform A-delta10 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 12.5893 | 1 | 1 |
Microtubule-associated protein tau | Homo sapiens (human) | Potency | 12.8631 | 1 | 2 |
mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 2.5119 | 1 | 1 |
nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 7.9433 | 1 | 1 |
Nrf2 | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 38.0659 | 3 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 0.2214 | 1 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 26.0952 | 1 | 2 |
Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 16.7855 | 1 | 1 |
nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 1.2589 | 1 | 1 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 51.0057 | 2 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
Parkin | Homo sapiens (human) | Potency | 40.8708 | 1 | 2 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 26.4222 | 2 | 2 |
peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 21.8750 | 5 | 7 |
PINK1 | Homo sapiens (human) | Potency | 40.8708 | 1 | 2 |
plasminogen precursor | Mus musculus (house mouse) | Potency | 1.1220 | 1 | 1 |
PPM1D protein | Homo sapiens (human) | Potency | 14.7403 | 1 | 2 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 6.4710 | 3 | 4 |
pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 2.4362 | 1 | 2 |
progesterone receptor | Homo sapiens (human) | Potency | 7.4632 | 2 | 4 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 21.7090 | 2 | 4 |
regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 13.5879 | 1 | 3 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 34.6466 | 3 | 4 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 16.6986 | 4 | 7 |
SMAD family member 2 | Homo sapiens (human) | Potency | 6.8583 | 2 | 3 |
SMAD family member 3 | Homo sapiens (human) | Potency | 6.8583 | 2 | 3 |
Smad3 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 24.9054 | 1 | 2 |
TDP1 protein | Homo sapiens (human) | Potency | 10.6307 | 2 | 13 |
thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 56.2341 | 1 | 1 |
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 8.8216 | 2 | 4 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 16.7855 | 1 | 1 |
transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 1.1220 | 1 | 1 |
urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 1.1220 | 1 | 1 |
USP1 protein, partial | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 17.5823 | 2 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 18.7413 | 2 | 3 |
vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 0.0488 | 1 | 2 |
Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 1.1970 | 1 | 1 |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 1.8000 | 1 | 1 |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 4.0405 | 2 | 2 |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 1.4059 | 2 | 2 |
Androgen receptor | Homo sapiens (human) | IC50 | 0.0061 | 2 | 2 |
Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2790 | 2 | 3 |
Androgen receptor | Homo sapiens (human) | Ki | 0.0029 | 5 | 5 |
Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 0.0048 | 1 | 1 |
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 1 |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 19.1400 | 1 | 1 |
Bile salt export pump | Homo sapiens (human) | IC50 | 17.6433 | 3 | 3 |
Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 32.2000 | 1 | 1 |
Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 1 |
Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 150.0000 | 1 | 1 |
Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 2,818.3800 | 1 | 1 |
Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 23.2000 | 1 | 1 |
Estrogen receptor | Homo sapiens (human) | IC50 | 0.9240 | 2 | 2 |
Estrogen receptor beta | Homo sapiens (human) | IC50 | 0.9240 | 2 | 2 |
Glucocorticoid receptor | Homo sapiens (human) | IC50 | 0.0130 | 3 | 3 |
Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.0124 | 6 | 6 |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 11.6000 | 1 | 1 |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0190 | 1 | 1 |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.0086 | 1 | 1 |
GTPase KRas | Homo sapiens (human) | IC50 | 0.9000 | 6 | 6 |
GTPase KRas | Homo sapiens (human) | Ki | 47.5000 | 2 | 2 |
Heme oxygenase 2 | Homo sapiens (human) | IC50 | 7.6400 | 1 | 1 |
Histamine H2 receptor | Homo sapiens (human) | IC50 | 27.9200 | 1 | 1 |
Histamine H2 receptor | Homo sapiens (human) | Ki | 27.4530 | 1 | 1 |
Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 1.1970 | 3 | 3 |
Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 22.5000 | 1 | 1 |
Myosin heavy chain, non-muscle | Drosophila melanogaster (fruit fly) | IC50 | 200.0000 | 1 | 1 |
Myosin IC heavy chain | Acanthamoeba castellanii | IC50 | 150.0000 | 1 | 1 |
Myosin-10 | Homo sapiens (human) | IC50 | 4.6000 | 1 | 1 |
Myosin-14 | Mus musculus (house mouse) | IC50 | 3.2000 | 1 | 1 |
Myosin-2 heavy chain | Dictyostelium discoideum | IC50 | 4.9000 | 1 | 1 |
Myosin-2 heavy chain, non muscle | Acanthamoeba castellanii | IC50 | 83.0000 | 1 | 1 |
Myosin-4 | Oryctolagus cuniculus (rabbit) | IC50 | 0.2200 | 1 | 1 |
Myosin-7 | Sus scrofa (pig) | IC50 | 1.2000 | 1 | 1 |
Myosin-9 | Homo sapiens (human) | IC50 | 4.0000 | 1 | 1 |
Nonmuscle myosin heavy chain | Gallus gallus (chicken) | IC50 | 1.8000 | 1 | 1 |
Progesterone receptor | Homo sapiens (human) | IC50 | 2.5081 | 4 | 4 |
Progesterone receptor | Homo sapiens (human) | Ki | 0.0005 | 8 | 8 |
Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 2,400.0000 | 1 | 1 |
Quinone oxidoreductase | Homo sapiens (human) | IC50 | 8.4400 | 1 | 1 |
Reticulon-4 | Homo sapiens (human) | IC50 | 14.6100 | 1 | 1 |
Sodium- and chloride-dependent betaine transporter | Mus musculus (house mouse) | IC50 | 331.1310 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | IC50 | 2,779.9967 | 3 | 3 |
Sodium- and chloride-dependent GABA transporter 2 | Homo sapiens (human) | IC50 | 154.5000 | 2 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | Mus musculus (house mouse) | IC50 | 378.8895 | 4 | 4 |
Sodium- and chloride-dependent GABA transporter 3 | Homo sapiens (human) | IC50 | 41.2000 | 2 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | Mus musculus (house mouse) | IC50 | 55.3998 | 3 | 3 |
Synaptic vesicle membrane protein VAT-1 homolog | Homo sapiens (human) | IC50 | 4.5100 | 2 | 2 |
Toll-like receptor 4 | Homo sapiens (human) | IC50 | 1.4000 | 1 | 1 |
Unconventional myosin-Ib | Rattus norvegicus (Norway rat) | IC50 | 150.0000 | 1 | 1 |
Unconventional myosin-Va | Mus musculus (house mouse) | IC50 | 150.0000 | 1 | 1 |
Unconventional myosin-X | Bos taurus (cattle) | IC50 | 150.0000 | 1 | 1 |
Unconventional myosin-XV | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |